ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 66 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $430 | -24.6% | 57,934 | -3.9% | 0.00% | -40.0% |
| Q1 2023 | $570 | +15.4% | 60,277 | +30.1% | 0.01% | -28.6% |
| Q4 2022 | $494 | -99.7% | 46,347 | +160.4% | 0.01% | +250.0% |
| Q3 2021 | $158,000 | +69.9% | 17,800 | +49.6% | 0.00% | +100.0% |
| Q4 2020 | $93,000 | – | 11,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corton Capital Inc. | 13,966 | $103,000 | 0.13% |
| Delphia (USA) Inc. | 14,226 | $105,000 | 0.12% |
| Sentinus, LLC | 22,500 | $166,000 | 0.10% |
| Intrepid Financial Planning Group LLC | 20,000 | $148,000 | 0.08% |
| PERRITT CAPITAL MANAGEMENT INC | 12,000 | $89,000 | 0.06% |
| J. Goldman & Co LP | 148,738 | $1,098,000 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 88,966 | $657,000 | 0.02% |
| EMFO, LLC | 1,666 | $12,000 | 0.01% |
| Virtu Financial LLC | 12,590 | $93,000 | 0.01% |
| Jump Financial, LLC | 23,400 | $173,000 | 0.01% |